Many patients arrive having already tried filler — or having been advised toward it — and still feel that something is off. The volume looks corrected. The shadows are softer. But the skin itself still looks tired, crepey, or textured in a way that no amount of volumisation has touched. This is not a failure of technique. It is a failure of tool selection.
Why Filler and PDRN Operate on Different Problems
Filler addresses structural volume loss. As the deep fat compartments thin and the bony scaffold resorbs with age, tissue descends and hollows form. Hyaluronic acid or other volumising agents placed at the correct anatomical depth can restore support, re-drape soft tissue, and reduce shadowing. This is legitimate, well-evidenced medicine when performed with proper anatomical understanding — see how Tune Clinic approaches filler as a structural tool rather than a reflex correction.
But fine surface lines — the crow’s feet that fan from the lateral canthus, the fine perioral creases that gather with repeated muscle contraction — do not live in the deep fat. They live in the dermis itself. Specifically, they reflect a deterioration of the papillary and reticular dermis: thinning collagen networks, reduced elastin organisation, and declining fibroblast activity. Placing volume nearby does not remodel skin tissue. The structural problem and the skin-quality problem are separate, and they require separate answers.
What PDRN Is and What It Actually Does
Polydeoxyribonucleotide (PDRN) is a bioactive compound derived from salmon DNA, purified and standardised for injectable medical use. Rejuran, the formulation used at Tune Clinic, has an established evidence base in Korean and international dermatology literature for its effects on skin regeneration.
The mechanism is reasonably well characterised. PDRN acts primarily as an adenosine A2A receptor agonist. Stimulation of this receptor pathway:
- Upregulates fibroblast proliferation and migration
- Increases production of type I and type III collagen
- Promotes angiogenesis in the treated zone
- Reduces inflammatory cytokine activity, which would otherwise degrade existing matrix
The net clinical effect — observed over a course of treatments — is measurable improvement in skin thickness, elasticity, and surface texture. These are changes occurring within the dermis, not imposed from outside it.
Fine lines in the crow’s feet zone are a skin quality problem. Injecting filler laterally to ‘support’ the area does not change the structural integrity of the dermis one millimetre above. The two conversations belong in separate columns on the treatment plan.
Delivery Precision: Why Depth Matters
The papillary dermis — the uppermost layer of the dermis, sitting just beneath the epidermis — is the primary target for Rejuran injection in fine-line treatment. This is a shallow plane. Microneedle delivery at the correct depth distributes PDRN where fibroblast populations are most relevant to surface texture, without the trauma and imprecision of broader needling approaches.
The difference between a skin booster and a structural filler session
Skin boosters, including PDRN formulations, are sometimes conflated with fillers because both involve injectable syringes and both carry aesthetic goals. The distinction physicians make is:
- Filler occupies space and provides mechanical support; its effect is largely immediate and physical
- PDRN signals biology; its effect is gradual, cumulative, and dependent on the patient’s own regenerative capacity
This matters for expectation-setting. A course of Rejuran will not produce the instant visual shift that volume replacement does. What it produces — across three to four sessions typically spaced three to four weeks apart — is skin that behaves differently: smoother, more resilient, with fine lines that are genuinely reduced rather than filled around.
Which Patients Benefit Most
Rejuran is not a universal first-line answer. Physician assessment before any skin booster course should consider:
- The nature of the line itself. Dynamic lines formed primarily by muscle contraction respond better to neuromodulator treatment first. Static fine lines with a textural or crepey quality are more suitable for PDRN.
- Skin thickness and baseline quality. Significantly thinned or sun-damaged skin may require a longer course and realistic timelines.
- What else is on the treatment plan. PDRN can be sequenced alongside structural treatments — volumisation, collagen-stimulating energy devices — as part of a layered plan, not as a standalone correction for all concerns.
- Patient expectations. The gradual biology of PDRN requires patients who understand that tissue repair is not a single-session event.
For patients with crow’s feet, perioral crepiness, or generalised fine surface texture that has persisted or worsened despite prior volumisation, PDRN often represents the missing layer in a treatment plan that was otherwise addressing the right problems in the wrong tissue plane. The physician’s role is to identify which layer is actually responsible for what the patient is seeing — and to resist the instinct to default to volume when the evidence points elsewhere.
Ready to plan your treatment?
Tune Clinic Apgujeong offers English-language consultations with Dr. Ju and Dr. Cha — a structured assessment, not a sales call.
→ Book an appointment to pick a time that fits your Seoul itinerary.
→ Message us on WhatsApp to ask in English before you commit.
